Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.
Nirvana Life Sciences Inc. (NIRV)
Nirvana Life Sciences Inc. (NIRV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
BMO Nesbitt Burns Inc. | 1,000 | 0.105 | 0.295 | 500 | BMO Nesbitt Burns Inc. |
TD Securities Inc. | 500 | 0.105 | 0.30 | 500 | TD Securities Inc. |
CIBC World Markets Inc. | 5,000 | 0.10 | 0.40 | 500 | W.D. Latimer Co. Limited |
CIBC World Markets Inc. | 6,000 | 0.04 | 0.50 | 500 | W.D. Latimer Co. Limited |
W.D. Latimer Co. Limited | 1,000 | 0.035 | 0.80 | 2,000 | TD Securities Inc. |
TD Securities Inc. | 33,000 | 0.03 | 0.85 | 500 | TD Securities Inc. |
TD Securities Inc. | 100,000 | 0.005 | 0.00 | 0 | |
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
2 | 1,500 | 0.105 | 0.295 | 500 | 1 |
1 | 5,000 | 0.10 | 0.30 | 500 | 1 |
1 | 6,000 | 0.04 | 0.40 | 500 | 1 |
1 | 1,000 | 0.035 | 0.50 | 500 | 1 |
1 | 33,000 | 0.03 | 0.80 | 2,000 | 1 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
---|---|---|---|---|---|---|
Apr 1, 19:31 | 0.105 | -0.195 | 500 | BMO Nesbitt Burns Inc. | Anonymous | CSE |
Apr 1, 14:54 | 0.115 | -0.185 | 500 | W.D. Latimer Co. Limited | Virtu Canada Corp. | CSE |
Apr 1, 14:54 | 0.15 | -0.15 | 500 | W.D. Latimer Co. Limited | Virtu Canada Corp. | CSE |
Mar 31, 14:39 | 0.30 | 0.00 | 500 | Virtu Canada Corp. | Scotia Capital Inc. | CSE |
Mar 31, 14:39 | 0.30 | 0.00 | 2,000 | Virtu Canada Corp. | Scotia Capital Inc. | CSE |
Company Info
SEDAR Information
Company Info
Capitalization
News Releases
News Release- Share Consolidation
MCTO Update
Bulletins
2025-0326 - Consolidation - Nirvana Life Sciences Inc. (NIRV)
Le 21 mars/March 2025
Nirvana Life Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
As a result, the number of outstanding shares will be reduced to approximately 4,823,301 common shares.
The name and symbol will not change.